Trial intelligence / Profile preview

ENRADAS: Effects of NSAIDs on Radiographic Damage in Ankylosing Spondylitis

NCT00715091Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Sep 2008
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of diclofenac in ankylosing spondylitis (AS) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Mean Radiographic Change of the Spine at 2 years. Started Sep 2008; status: completed.

02

Drugs

diclofenac
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on NCT00715091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00715091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call